Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification

Gut

Volumn 45, Issue 2, 1999, Pages 172-180

  Lundell, L R ^j   Dent, J ^a   Bennett, J R ^b   Blum, A L ^c   Armstrong, D ^d   Galmiche, J P ^e   Johnson, F ^f   Hongo, M ^g   Richter, J E ^h   Spechler, S J ⁱ   Tytgat, G N J ^j   Wallin, L ^j  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b Remenham House   (United Kingdom)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^e HÔTEL DIEU   (France)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j NONE

more..

Author keywords

Acid reflux; Columnar lined mucosa; Endoscopy; Heartburn; Oesophagitis; Omeprazole; Stricture

Indexed keywords

OMEPRAZOLE;

ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ESOPHAGOSCOPY; ESOPHAGUS MUCOSA; ESOPHAGUS PH; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RELAPSE; RELIABILITY; TREATMENT OUTCOME; UNITED STATES;

EID: 0032816679     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.2.172     Document Type: Article

References (33)

1. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51(suppl I):24-9.
2. Bennett JR, Chapman RWG, Harvey RF, et al. Management guidelines for gastro-oesophageal reflux disease. The European Digestive Disease Week, Amsterdam, 1991:16-54.
3. Spechler SJ. Complications of gastro-oesophageal reflux disease. In Castell DO, editor. The oesophagus. Boston: Lattle Brown and Co., 1992:543-56.
4. Dent J, Bremner CG, Collens MJ, et al. Barrett's oesophagus. Working party report to the World Congress of Gastroenterology, Sydney 1990. J Gastroenterol Hepatol 1991;6:1-22.
5. Lundell L. Long-term treatment of gastro-oesophageal reflux disease with omeprazole. Scand J Gastroenterol 1994;29(suppl 201):74-8.
6. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of oesophagits: a progress report on observer agreement. Gastroenterology 1996;111:85-92.
7. Bytzer P, Havelund T, Möller Hanses J. Interobserver variation in the endoscopic diagnosis of reflux oesophagitis. Scand J Gastroenterol 1993;28:119-25.
8. Armstrong D, Emde C, Inauen W, Blum AL. Diagnostic assessment of gastrooesophageal reflux disease: what is possible vs what is practical? Hepatogastroenterology 1992;39:3-13.
9. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measurement 1960;20:37-46.
10. Johnsson F, Weywadt L, Solhaug JH, et al. One week omeprazole treatment in the diagnosis of gastrooesophageal reflux disease. Scand J Gastroenterol 1998;33:15-20.
11. Carlsson R. Gastroesophageal reflux disease (GERD) in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998;10:119-24.
12. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-9.
13. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992;304:1491-4.
14. Savary M, Miller G. L'oesophage. Manuel at atlas d'endoscopic. Soleure; Garsman Ab, 1977.
15. Monnier P, Savary M. Contribution of endoscopy to gastro-oesophageal reflux disease. Scand J Gastroenterol 1984;106:26.
16. Ollyo JB, Gontollier C, Brossard E, et al. La nouvelle classification de Savary des ooesophagites de reflux. Acta Endoscopica 1992;22:307.
17. Savary M, Miller G. The oesophagus. Handbook and atlas of endoscopy. Solothorn, Switzerland: Gassman AG, 1978.
18. Endo M, Hideck-Ide H. Endoscopic staining in early diagnosis of oesophageal cancer. Tokyo: Japan Scientific Societis Press, 1991.
19. Lundell L. Acid suppression in the long term treatment of peptric strictures and Barrett's oesophagus. Digestion 1992;51(suppl 1):49-58.
20. Ghillebert G, Demeyere AM, Jansson J, et al. How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995;40:1317-24.
21. Hatlebakk JG, Berstad A. Endoscopic grading of reflux oesophagitis: what observations correlate with gastro-oesophageal reflux? Scand J Gastroenterol 1997;32:760-5.
22. Galmiche JP, Bruley des Varannes S. Symptoms and diseases severity in gastro-oesophageal reflux disease. Scand J Gastroenterol 1994;29:62-8.
23. Pace F, Santalucia F, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 1992;32:848-58.
24. Schindlbeck NE, Klauser AG, Berghammer G, et al. Three year follow up of patients with gastro-oesophageal reflux disease. Gut 1992;33:1016-19.
25. Tytgat GN, Nio CY, Schotborgh RH. Reflux oesophagitis. Scand J Gastroenterol 1990;25(suppl 175):1-12.
26. Baldi F, Ferrarini F, Langanesi A, et al. Acid gastro-oesophageal reflux and symptom occurrence. Analyses of some factors influencing their association. Dig Dis Sci 1989;34:1890-3.
27. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
28. Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in the treatment of reflux oesophagitis. Results of double-blind, randomized, Scandinavian multicentre trial. Scand J Gastroenterol 1988;23:625-32.
29. Koelz HR, Birchler R, Bretholz A, et al. Healing and relapse of reflux oesophagitis during treatment with ranitidine. Gastroenterology 1986;91:1198-205.
30. Tytgat GN, Molenaar CBH. Grading endoscopic severity in gastroesophageal reflux disease. Rumanian Journal of Gastroenterology 1994;3:91-3.
31. Tytgat GNJ, Hansen OJA, Carling L, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992;27:175-83.
32. Dent J, Yeomans ND, Mackinnon M, et al. Omeprazole versus ranitidine for prevention of relapse in reflux oesophagitis. A controlled double-blind trial of the efficacy and safety. Gut 1994;35:590-8.
33. Blum AL, Adami B, Bouzo MH, et al. Effect of cisapride on relapse of oesophagitis. A multinational placebo-controlled trial in patients healed with an antisecretory drug. Dig Dis Sci 1993;38:551-60.